Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acyclovir Dosage Regimens in Obese Patients
NCT05589688Phase 1Recruiting
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Apr 2024
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of aciclovir in herpes simplex virus infection and varicella zoster virus infection, sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Renal elimination clearance at Day 1. Started Apr 2024; status: recruiting.
02
Drugs
aciclovir
03
Conditions
herpes simplex virus infectionvaricella zoster virus infection
Beyond the preview
Go deeper on NCT05589688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05589688.